Cargando…

Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection

BACKGROUND: Research has shown that hepatitis B virus (HBV) genotypes are closely linked to the clinical manifestations, treatment, and prognosis of the disease. OBJECTIVE: To study the association between genotype and drug-resistant HBV mutations in 620 Chinese patients with chronic HBV infection....

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Wenhao, Zhang, Guanbin, Guo, Shujun, Li, Weijie, Sun, Lanhua, Xiang, Guangxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425391/
https://www.ncbi.nlm.nih.gov/pubmed/25982306
http://dx.doi.org/10.1016/j.bjid.2015.03.012
_version_ 1784778438665568256
author Hua, Wenhao
Zhang, Guanbin
Guo, Shujun
Li, Weijie
Sun, Lanhua
Xiang, Guangxin
author_facet Hua, Wenhao
Zhang, Guanbin
Guo, Shujun
Li, Weijie
Sun, Lanhua
Xiang, Guangxin
author_sort Hua, Wenhao
collection PubMed
description BACKGROUND: Research has shown that hepatitis B virus (HBV) genotypes are closely linked to the clinical manifestations, treatment, and prognosis of the disease. OBJECTIVE: To study the association between genotype and drug-resistant HBV mutations in 620 Chinese patients with chronic HBV infection. METHODS: HBV DNA levels were determined using real-time quantitative PCR in plasma samples. Microarrays were performed for the simultaneous detection of HBV genotypes (HBV/B, C, and D) and drug-resistance-related hotspot mutations. A portion of the samples analyzed using microarrays was selected randomly and the data were confirmed using direct DNA sequencing. RESULTS: Most samples were genotype C (471/620; 76.0%), followed by genotype B (149/620; 24.0%). Among the 620 patient samples, 17 (2.7%) had nucleotide analogs (NA) resistance-related mutations. Of these, nine and eight patients carried lamivudine (LAM)-/telbivudine (LdT)-resistance mutations (rtL180M, rtM204I/V) and adefovir (ADV)-resistance mutations (rtA181T/V, rtN236T), respectively. No patients had both lamivudine (LAM)- and either adefovir (ADV) or entecavir (ETV) resistance mutations. Additionally, out of the 620 patient samples, 64.0% (397/620) were also detected with the precore stop-codon mutation (G1896A) by microarray assay. CONCLUSION: The results of the current study revealed that the prevalence of nucleotide analogs (NA)-resistance in Chinese hospitalized HBV-positive patients was so low that intensive nucleotide analogs (NA)-resistance testing before nucleotide analog (NA) treatment might not be required. In addition, the present study suggests that chronic HBV patients with genotype C were infected with fitter viruses and had an increased prevalence of nucleotide analogs (NA)-resistance mutations compared to genotype B virus.
format Online
Article
Text
id pubmed-9425391
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94253912022-08-31 Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection Hua, Wenhao Zhang, Guanbin Guo, Shujun Li, Weijie Sun, Lanhua Xiang, Guangxin Braz J Infect Dis Original Article BACKGROUND: Research has shown that hepatitis B virus (HBV) genotypes are closely linked to the clinical manifestations, treatment, and prognosis of the disease. OBJECTIVE: To study the association between genotype and drug-resistant HBV mutations in 620 Chinese patients with chronic HBV infection. METHODS: HBV DNA levels were determined using real-time quantitative PCR in plasma samples. Microarrays were performed for the simultaneous detection of HBV genotypes (HBV/B, C, and D) and drug-resistance-related hotspot mutations. A portion of the samples analyzed using microarrays was selected randomly and the data were confirmed using direct DNA sequencing. RESULTS: Most samples were genotype C (471/620; 76.0%), followed by genotype B (149/620; 24.0%). Among the 620 patient samples, 17 (2.7%) had nucleotide analogs (NA) resistance-related mutations. Of these, nine and eight patients carried lamivudine (LAM)-/telbivudine (LdT)-resistance mutations (rtL180M, rtM204I/V) and adefovir (ADV)-resistance mutations (rtA181T/V, rtN236T), respectively. No patients had both lamivudine (LAM)- and either adefovir (ADV) or entecavir (ETV) resistance mutations. Additionally, out of the 620 patient samples, 64.0% (397/620) were also detected with the precore stop-codon mutation (G1896A) by microarray assay. CONCLUSION: The results of the current study revealed that the prevalence of nucleotide analogs (NA)-resistance in Chinese hospitalized HBV-positive patients was so low that intensive nucleotide analogs (NA)-resistance testing before nucleotide analog (NA) treatment might not be required. In addition, the present study suggests that chronic HBV patients with genotype C were infected with fitter viruses and had an increased prevalence of nucleotide analogs (NA)-resistance mutations compared to genotype B virus. Elsevier 2015-05-14 /pmc/articles/PMC9425391/ /pubmed/25982306 http://dx.doi.org/10.1016/j.bjid.2015.03.012 Text en © 2015 Elsevier Editora Ltda. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Hua, Wenhao
Zhang, Guanbin
Guo, Shujun
Li, Weijie
Sun, Lanhua
Xiang, Guangxin
Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection
title Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection
title_full Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection
title_fullStr Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection
title_full_unstemmed Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection
title_short Microarray-based genotyping and detection of drug-resistant HBV mutations from 620 Chinese patients with chronic HBV infection
title_sort microarray-based genotyping and detection of drug-resistant hbv mutations from 620 chinese patients with chronic hbv infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425391/
https://www.ncbi.nlm.nih.gov/pubmed/25982306
http://dx.doi.org/10.1016/j.bjid.2015.03.012
work_keys_str_mv AT huawenhao microarraybasedgenotypinganddetectionofdrugresistanthbvmutationsfrom620chinesepatientswithchronichbvinfection
AT zhangguanbin microarraybasedgenotypinganddetectionofdrugresistanthbvmutationsfrom620chinesepatientswithchronichbvinfection
AT guoshujun microarraybasedgenotypinganddetectionofdrugresistanthbvmutationsfrom620chinesepatientswithchronichbvinfection
AT liweijie microarraybasedgenotypinganddetectionofdrugresistanthbvmutationsfrom620chinesepatientswithchronichbvinfection
AT sunlanhua microarraybasedgenotypinganddetectionofdrugresistanthbvmutationsfrom620chinesepatientswithchronichbvinfection
AT xiangguangxin microarraybasedgenotypinganddetectionofdrugresistanthbvmutationsfrom620chinesepatientswithchronichbvinfection